Osel DevicesNSE:OSELDEVICE +3.32%19 EBITDA Margin % is 16.80% as of Sep. 2025, which is 58% above its 10-year median of 10.63. GuruFocus rates NSE:OSELDEVICE with a GF Score™ of 19/100. The stock has 4 warning signs investors should review. Among 816 Medical Devices & Instruments companies, Osel Devices ranks better than 72.43% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Osel Devices's EBITDA for the
six
months ended in Sep. 2025 was ₹247 Mil. Osel Devices's Revenue for the
six
months ended in Sep. 2025 was ₹1,469 Mil. Therefore, Osel Devices's EBITDA margin for the quarter that ended in Sep. 2025 was 16.80%.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Osel Devices EBITDA Margin % Related Terms
Osel Devices EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Osel Devices's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:OSELDEVICE vs ABT, SYK, MDT: EBITDA Margin % Comparison
For the Medical Devices subindustry, Osel Devices's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Osel Devices EBITDA Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Osel Devices's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Osel Devices's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Osel Devices (NSE:OSELDEVICE) has a EBITDA Margin % of 16.80% as of Sep. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Osel Devices and its competitors. This is 58% above median its historical median of 10.63. Over the past decade, Osel Devices' EBITDA Margin % has ranged from 5.27 to 18.26. According to the industry distribution chart, Osel Devices ranks #225 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 27.6%.
Is Osel Devices' EBITDA Margin % too high?
Osel Devices' current EBITDA Margin % of 16.80% is 58% above median its 10-year median of 10.63. Over the past 10 years, this metric has ranged from a low of 5.27 to a high of 18.26. The Medical Devices & Instruments industry median EBITDA Margin % is 7.39. Osel Devices' value of 16.80% is 127.5% above this industry median. Based on the distribution chart, Osel Devices ranks #225 out of 816 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Osel Devices has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Osel Devices' EBITDA Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Osel Devices ranks #225 out of 816 companies for EBITDA Margin %. This puts Osel Devices in the upper half of its industry. The industry median EBITDA Margin % is 7.39. Osel Devices' value of 16.80% is 127.5% above this benchmark. Historically, Osel Devices' own EBITDA Margin % has ranged from 5.27 to 18.26 over the past decade. While the company's 10-year median is 10.63 vs. the industry median of 7.39, Osel Devices has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.39, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Osel Devices's current EBITDA Margin % of 16.80% is 127.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Osel Devices and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.39 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Osel Devices's current EBITDA Margin % is 16.80%, which is 58% above median its own 10-year median of 10.63. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Osel Devices stock overvalued right now?
Osel Devices (NSE:OSELDEVICE) has a current EBITDA Margin % of 16.80%. The current EBITDA Margin % is 16.80%, which is 58% above median its 10-year median of 10.63 and 127.5% above the Medical Devices & Instruments industry median of 7.39. Osel Devices' overall GF Score™ is 19/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Osel Devices (NSE:OSELDEVICE), the current EBITDA Margin % is 16.80% as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Osel Devices Ltd is engaged in the manufacture, trade, retail, wholesale, import, export, warehousing, storage, distribution, assembly, repair, maintenance, integration, operation, testing, installation, and resale of hearing aids and LED display components, parts, and accessories. The company also carries out research and development activities related to all kinds of hearing aids, components, parts, and accessories. it offers variuos products including advanced hearing aids designed to improve auditory experience and LED solutions tailored to various industries, while also distributing Mobile products across India. it generates majority of revenue from hearing aids.
19GF Score
Get the complete analysis for NSE:OSELDEVICE
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:OSELDEVICE has been successfully added to your 